Epstein Secrets

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. EFTA00351823 OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

pment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur